Browse > Article

Isolation and Structural Determination of Squalene Synthase Inhibitor from Prunus mume Fruit  

Choi, Sung-Won (Department of Food and Culinary Art, Osan College)
Hur, Nam-Yoon (Department of Food and Culinary Art, Osan College)
Ahn, Soon-Cheol (Department of Microbiology and Immunology, and Medical Research Institute, Pusan National University College of Medicine)
Kim, Dong-Seob (College of Natural Resources and Life Sciences, Pusan National University)
Lee, Jae-Kwon (Department of Foods and Biotechnology, Kyonggi University)
Kim, Dae-Ok (Institute of Life Science and Resources, Department of Food Science and Biotechnology, Kyung Hee University)
Park, Seung-Kook (Institute of Life Science and Resources, Department of Food Science and Biotechnology, Kyung Hee University)
Kim, Byun-Yong (Institute of Life Science and Resources, Department of Food Science and Biotechnology, Kyung Hee University)
Baik, Moo-Yeol (Institute of Life Science and Resources, Department of Food Science and Biotechnology, Kyung Hee University)
Publication Information
Journal of Microbiology and Biotechnology / v.17, no.12, 2007 , pp. 1970-1975 More about this Journal
Abstract
Squalene synthase plays an important role in the cholesterol biosynthetic pathway. Inhibiting this enzyme in hypercholesterolemia can lower not only plasma cholesterol but also plasma triglyceride levels. A squalene synthase inhibitor was screened from Prunus mume fruit, and then purified via sequential processes of ethanol extraction, HP-20 column chromatography, ethyl acetate extraction, silica gel column chromatography, and crystallization. The squalene synthase inhibitor was identified as chlorogenic acid with a molecular mass of 354 Da and a molecular formula of $C_{16}H_{18}O_9$ based on UV spectrophotometry, $^1H$ and $^{13}C$ NMRs, and mass spectrometry. Chlorogenic acid inhibited the squalene synthase of pig liver with an $IC_{50}$ level of 100 nM. Since chlorogenic acid was an effective inhibitor against the squalene synthase of an animal source, it may be a potential therapeutic agent for hypercholesterolemia.
Keywords
Squalene synthase inhibitor; chlorogenic acid; Prunus mume; hypercholesterolemia;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
1 Choi, S. W., D. S. Kim, N. Y. Hur, C. S. Park, and M. Y. Baik. 2003. Purification and identification of squalene synthase inhibitor isolated from fermented soybean paste. Food Sci. Biotechnol. 14: 89-93
2 Haria, M. and D. Mctavish. 1997. Pravastatin. Drugs 53: 299-336   DOI   ScienceOn
3 Huh, S. J., K. H. Lee, H. S. Yun, D. J. Paik, J. M. Kim, and J. H. Youn. 2007. Functions of metallothionein generating interleukin-10-producing regulatory CD4+ cells potentiate suppression of collagen induced arthritis. J. Microbiol. Biotechnol. 17: 348-358   과학기술학회마을
4 Ishihara, T., H. Kakuta, H. Moritani, T. Ugawa, S. Sakamoto, S. Tsukamoto, and I. Yanagisawa. 2003. Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: Enzyme inhibition and effects on plasma lipid levels. Bioorg. Med. Chem. 11: 3735-3745   DOI   ScienceOn
5 Jee, H. J. 1999. Health Foods from Herbs, p. 52. Seoul National University Press, Seoul, Korea
6 Kuswik, R. G. and H. C. Rilling. 1987. Squalene synthetase. Solubilization and partial purification of squalene synthetase, copurification of presqualene pyrophosphate and squalene synthetase activities. J. Biol. Chem. 262: 1505-1510
7 Lim, Y.-H., I.-H. Kim, J.-J. Seo, and J.-K. Kim. 2006. Tyrosinase inhibitor from the flowers of Impatiens balsamina. J. Microbiol. Biotechnol. 16: 1977-1983   과학기술학회마을
8 Nishimoto, T., Y. Amano, R. Tozawa, E. Ishikawa, Y. Imura, H. Yukimasa, and Y. Sugiyama. 2003. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro. Br. J. Pharmacol. 139: 911-918   DOI   ScienceOn
9 Kasim, S. E., R. C. Leboeuf, S. Khilnani, L. Tallapaka, D. Dayanada, and L. C. Jenk. 1992. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. J. Lipid Res. 33: 1-7
10 Baxter, A., B. J. Fitzgerald, J. L. Hutson, A. D. McCarthy, J. M. Motteram, B. C. Ross, M. Sapra, M. A. Snowden, N. S. Watson, R. J. Williams, and C. Wright. 1992. Squalestatin, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. J. Biol. Chem. 267: 11705-11708
11 Lipid Research Clinics. 1984. Lipid research clinics program. J. Am. Med. Assoc. 252: 2545-2548   DOI   ScienceOn
12 Poulter, C. D. and H. C. Rilling. 1981. Biosynthesis of Isoprenoid Compounds, pp. 413-441. Wiley Publisher, New York, U.S.A
13 Abe, I., J. C. Tomesch, S. Wattanasin, and G. D. Prestwich. 1993. Inhibitors of squalene biosynthesis and metabolism. Nat. Prod. Rep. 11: 279-293   DOI   ScienceOn
14 Cho, J.-Y., J.-H. Moon, H.-K. Kim, S.-J. Ma, S.-J. Kim, M.- Y. Jang, K. Kawazoe, Y. Takaishi, and K.-H. Park. 2006. Isolation and structural elucidation of antimicrobial compounds from buckwheat hull. J. Microbiol. Biotechnol. 16: 538-542   과학기술학회마을
15 Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
16 Agnew, W. S. 1985. Squalene synthetase. Methods Enzymol. 110: 359-375   DOI
17 Shepherd, J., S. M. Cobbe, I. Ford, C. G. Isles, A. R. Lorimer, P. W. MacFarlane, J. H. McKillop, and C. J. Packard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307   DOI   ScienceOn
18 Ha, C. G., J. K. Cho, C. H. Lee, Y. G. Chai, Y. A. Ha, and S. H. Shin. 2006. Cholesterol lowering effect of Lactobacillus plantarum isolated from human feces. J. Microbiol. Biotechnol. 16: 1201-1209   과학기술학회마을
19 Nardini, M., F. Natella, V. Gentili, M. Di-Felice, and C. Scaccini. 1997. Effect of caffeic acid dietary supplementation on the antioxidant defense system in rat: An in vivo study. Arch. Biochem. Biophys. 342: 157-160   DOI   ScienceOn
20 Hiyoshi, H., M. Yanagimachi, M. Ito, I. Ohtsuka, I. Yoshida, T. Saeki, and H. Tanaka. 2000. Effect of ER- 27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: Comparison with 3-hydroxy- 3-methylglutaryl-CoA reductase inhibitors. J. Lipid Res. 41: 1136-1144
21 Rodriguez, de Sotillo D. V. and M. Hadley. 2002. Chlorogenic acid modifies plasma and liver concentrations of cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J . Nutr. Biochem. 13: 717-726   DOI   ScienceOn
22 McClellan, K. J., L. R. Wiseman, and D. McTavish. 1998. Cerivastatin. Drugs 55: 415-422   DOI   ScienceOn
23 Bergstrom, J. D., M. M. Krutz, D. J. Rew, A. M. Amend, J. D. Karkas, R. D. Bostedor, V. S. Bansal, C. Dufresns, F. L. V. Middleworth, O. D. Hensens, J. M. Liesch, D. L. Zinc, K. E. Wilson, J. Onishi, J. A. Milligan, G. Bills, L. Kaplan, M. O. Nallin, R. G. Jenskins, L. Huang, M. S. Meinz, L. Quinn, R. U. Burg, Y. L. Kong, S. Mochales, M. Mojena, I. Martin, F. Pelaez, M. T. Diez, and A. W. Albert. 1993. Zaragozic acids: A family of metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA 90: 80-89
24 Biller, S. A., C. Forster, E. M. Gordon, T. Harrity, L. C. Rich, J. Marretta, and C. P. Ciosek. Jr. 1991. Isoprenyl phosphinylformates: New inhibitors of squalene synthetase. J. Med. Chem. 34: 1912-1914   DOI
25 Cho, J.-Y., G. J. Choi, S.-W. Lee, K. S. Jang, H. K. Lim, C. H. Lim, S. O. Lee, K. Y. Cho, and J.-C. Kim. 2006. Antifungal activity against Colletotrichum spp. of curcuminoids isolated from Curcuma longa L. rhizomes. J. Microbiol. Biotechnol. 16: 280-285   과학기술학회마을
26 Park, J. K., H. J. Cho, Y. H. Lim, Y. H. Cho, and C. H. Lee. 2002. Hypocholesterolemic effect of CJ90002 in hamsters: A potent inhibitor for squalene synthase from Paeonia moutan. J. Microbiol. Biotechnol. 12: 222-227
27 Dawson, M. J., J. E. Farthing, P. S. Marshall, R. F. Middleton, M. J. O'Neill, A. Shuttleworth, C. Stylli, R. M. Tait, P. M. Taylor, H. G. Wildman, A. D. Buss, D. Langley, and M. V. Hayes. 1992. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiot. 45: 639-647   DOI
28 Hiyoshi, H., M. Yanagimachi, M. Ito, T. Saeki, I. Yoshida, T. Okada, H. Ikuta, D. Shinmyo, K. Tanaka, N. Kurusu, and H. Tanaka. 2001. Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptorindependent mechanism. Eur. J. Pharmacol. 431: 345-352   DOI   ScienceOn
29 Poulter, C. D. 1991. Biosynthesis of non-head-to-tail terpenes. Formation of 1'-1 and 1'-3 linkages. Acc. Chem. Res. 23: 70-77   DOI
30 Feng, R., Y. Lu, L. L. Bowman, Y. Qian, V. Castranova, and M. Ding. 2005. Inhibition of activator protein-1, NFkappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 280: 27888-27895   DOI   ScienceOn
31 Koo, K.-C., D.-H. Lee, J.-H. Kim, H.-E. Yu, J.-S. Park, and J.-S. Lee. 2006. Production and characterization of antihypertensive angiotensin I-converting enzyme inhibitor from Pholiota adiposa. J. Microbiol. Biotechnol. 16: 757- 763   과학기술학회마을
32 Keller, R. K. and F. Vilsaint. 1993. Regulation of isoprenoid metabolism in rat liver: Near constant chain lengths of dolichy phosphate and ubiquinone are maintained during greatly altered rates of cholesterogenesis. Biochim. Biophy. Acta 1170: 20-25